Évaluation de la qualité de vie des patients sous hémodialyse en IraqRÉSUMÉ L'existence d'une maladie rénale chronique nécessite la mise en place d'une thérapie de remplacement rénal à vie, ce qui peut grandement impacter la qualité de vie des patients. La présente étude transversale avait pour objectif d'évaluer la qualité de vie des patients sous hémodialyse, ainsi que les facteurs de détérioration de la qualité de vie, à l'unité de dialyse de l'hôpital général de Bassora. Au total, 104 patients atteints de maladie rénale en phase terminale et sous hémodialyse ont été inclus à l'étude. Les données ont été collectées à l'aide du questionnaire d'évaluation de la qualité de vie de l'Organisation mondiale de la Santé. Des données sociodémographiques et cliniques ont également été recueillies. Sur les 104 patients, 57 % étaient des hommes, 73 % étaient âgés de plus de 45 ans, 87 % étaient issus de milieux socio-économiques moyen et faible, 70 % étaient sous dialyse depuis plus d'un an, 74 % disposaient d'un abord vasculaire de type fistule artério-veineuse, 34 % souffraient de diabète et 48 % avaient contracté le virus de l'hépatite. Tous les domaines de la qualité de vie (santé physique, psychologique, relations sociales et environnement) étaient affectés, le domaine physique étant celui le plus impacté. Un âge plus avancé, un statut socio-économique inférieur, une durée prolongée de la dialyse, un abord vasculaire par cathéter central, le fait d'être diabétique et d'avoir une sérologie positive au virus de l'hépatite étaient associés de façon significative à une diminution de la qualité de vie (p < 0,05). ABSTRACT Chronic kidney disease requires life-long renal replacement therapy, which can greatly impair the quality of life (QOL) of patients. This cross-sectional study aimed to assess the QOL of patients on haemodialysis, and the factors affecting it, at the dialysis unit of Basra General Hospital. A total of 104 patients with end-stage renal disease on haemodialysis were included. Data were collected using the World Health Organization QOL questionnaire. Sociodemographic and clinical data were also collected. Of the 104 patients, 57% were male, 73% were older than 45 years, 87% were of middle and low socioeconomic status, 70% had been on dialysis for more than 1 year, 74% had arteriovenous fistula vascular access, 34% had diabetes and 48% were positive for hepatitis virus. All domains of QOL (physical health, psychological, social relationships and environment) were affected; the physical domain was the most severely affected. Older age, lower socioeconomic status, longer duration of dialysis, central line vascular access, having diabetes and positive hepatitis serology were significantly associated with lower QOL (P < 0.05). العراق يف الكلوي الغسيل ملرىض احلياة جودة تقييم
Contrast-induced nephropathy is an important complication after cardiac catheterization, and is associated with accelerated renal disease, increased costs, mortality rate, need for dialysis and prolonged hospital stay. This study aim is to find its incidence and risk factors. It is a cross-sectional study on 160 patients admitted for diagnostic or therapeutic percutaneous coronary intervention in Basra Cardiac Center, from March to September 2016. Data collected were a complete history, examination, blood pressure, Echo study, fasting blood sugar, lipid profile, blood urea, serum creatinine and estimated glomerular filtration rate, the type and duration of procedure, volume of contrast, and after 48 hours renal function tests were repeated. Contrast-induced nephropathy has developed in 7 (8.3%) men and 5 (6.6%) women; 11 (10.8%) from 102 patients with dyslipidemia (P = 0.03); 8 (22.2%) from 36 with preexisting renal impairment (P = 0.01); 11 (10.9%) from 101 with hypertension (P = 0.02); 9 (13.6%) from 66 diabetic (P = 0.016); 9 (17.3%) from 52 smoker (P = 0.002); 4 (23.5%) from 17 alcohol drinkers (P = 0.026); 11 (11.2%) from 98 with ischemic heart disease (P = 0.02); and 9 (25.7%) from 35 with heart failure (P = <0.001). Also found in 1 (1.6%) from 64 diagnostic procedures; 11 (11.5%) from 96 therapeutic procedures (P = 0.016); 5 (3.7%) from 135 patients received < 300 ml of contrast; and 7 (28%) from 25 received ≥ 300 ml (P = 0.001). In conclusion contrast-induced nephropathy is aggravated by increasing age, diabetes mellitus, heart failure, ischemic heart disease, renal impairment, hypertension, dyslipidemia, smoking and alcohol use. The type of procedure (therapeutic vs. diagnostic), and large volume of contrast agent are important risk factors. Gender had no significant effect.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.